Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Bosch

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Hypertension|June 28, 2019
Evidence of neurodegeneration in individuals with only mildly elevated blood pressureSusanne Jung, Agnes Bosch, Nikolas Kohler, et al.
Clinical Kidney Journal|July 8, 2025
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney diseaseVenera Bytyqi, Dennis Kannenkeril, Axel Schmid, et al.
Cardiovascular Diabetology|September 5, 2021
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargineChristian Ott, Susanne Jung, Manuel Korn, et al.
ESC Heart Failure|September 20, 2021
Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failureJulie Kolwelter, Agnes Bosch, Susanne Jung, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2024
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular diseaseDennis Kannenkeril, Agnes Bosch, Julie Kolwelter, et al.
ESC Heart Failure|February 14, 2023
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failureAgnes Bosch, Marko Poglitsch, Dennis Kannenkeril, et al.
European Journal of Preventive Cardiology|June 27, 2025
Renal denervation improves capillary density in hypertensive patientsAgnes Bosch, Joanna M Harazny, Axel Schmid, et al.
American Journal of Nephrology|March 7, 2021
Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRIDennis Kannenkeril, Rolf Janka, Agnes Bosch, et al.
European Journal of Heart Failure|November 4, 2025
Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failureVenera Bytyqi, Dennis Kannenkeril, Julie Kolwelter, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2024
Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic VariantsChristian Delles, Roland E Schmieder, Rónán Daly, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Hypertension|June 28, 2019
Evidence of neurodegeneration in individuals with only mildly elevated blood pressureSusanne Jung, Agnes Bosch, Nikolas Kohler, et al.
Clinical Kidney Journal|July 8, 2025
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney diseaseVenera Bytyqi, Dennis Kannenkeril, Axel Schmid, et al.
Cardiovascular Diabetology|September 5, 2021
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargineChristian Ott, Susanne Jung, Manuel Korn, et al.
ESC Heart Failure|September 20, 2021
Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failureJulie Kolwelter, Agnes Bosch, Susanne Jung, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2024
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular diseaseDennis Kannenkeril, Agnes Bosch, Julie Kolwelter, et al.
ESC Heart Failure|February 14, 2023
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failureAgnes Bosch, Marko Poglitsch, Dennis Kannenkeril, et al.
European Journal of Preventive Cardiology|June 27, 2025
Renal denervation improves capillary density in hypertensive patientsAgnes Bosch, Joanna M Harazny, Axel Schmid, et al.
American Journal of Nephrology|March 7, 2021
Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRIDennis Kannenkeril, Rolf Janka, Agnes Bosch, et al.
European Journal of Heart Failure|November 4, 2025
Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failureVenera Bytyqi, Dennis Kannenkeril, Julie Kolwelter, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2024
Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic VariantsChristian Delles, Roland E Schmieder, Rónán Daly, et al.
Pageof 5